Literature DB >> 31678450

Intracranial Metastases from Prostate Carcinoma: Classification, Management, and Prognostication.

Mario Ganau1, Paolo Gallinaro2, Helene Cebula1, Antonino Scibilia1, Julien Todeschi1, Arthur Gubian1, Beniamino Nannavecchia1, Francesco Signorelli3, Raoul Pop4, Hugo-Andres Coca1, Francois Proust1, Salvatore Chibbaro1.   

Abstract

BACKGROUND: Prostate carcinomas rarely metastasize to the central nervous system but, when they do, dural localizations are as common as and far more aggressive than intraparenchymal ones. Those metastases can be further classified according to their extension toward the subdural or extradural space and can frequently simulate other pathologic conditions including chronic subdural hematomas, abscess, and primary bone tumors. Beside the challenges of the preoperative differential diagnostic and complexity of surgical planning and operative excision, subdural metastases seem to carry a much poorer prognosis.
METHODS: A series of consecutive patients admitted during a 12-year period through our oncall pathway for subdural/extradural collections or intraparenchymal lesions found, on histologic analysis, to represent intracranial prostate cancer metastases was retrospectively reviewed.
RESULTS: A total of 19 patients were included, but only 3 were diagnosed with small cell prostate carcinoma, while the majority had a primary prostate adenocarcinoma. Metastases could be classified as pure subdural space lesions, dural-based lesions, extradural/bony lesions, and pure intraparenchymal lesions. All patients with subdural metastases and 3 out of 5 patients with dural-based lesions required an emergency intervention due to rapidly deteriorating neurologic status. The mean follow-up in our series was 37 months; only subdural localizations had a remarkably unfavorable outcome.
CONCLUSIONS: Supported by our experience and the review of the literature, we suggest that a low threshold for contrast-enhanced computed tomography/magnetic resonance imaging is advisable in case of suspicious subdural collection, even in an emergency setting, for patients with previous medical history of prostate cancer.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic subdural hematoma; Dura-mater based lesion; Meningioma; Metastasis; Prostate carcinoma; Vault osteolytic lesion

Mesh:

Year:  2019        PMID: 31678450     DOI: 10.1016/j.wneu.2019.10.125

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  4 in total

1.  Case Report: Creeping Growth in Lymphoplasmacyte-Rich Meningioma-A Radiologic Variant.

Authors:  Jiuhong Li; Xin Zan; Min Feng; Xueyun Deng; Si Zhang; Wenke Liu
Journal:  Front Surg       Date:  2021-12-14

Review 2.  Prostate Cancer Brain Metastasis: Review of a Rare Complication with Limited Treatment Options and Poor Prognosis.

Authors:  Kobisha Rajeswaran; Kaitlin Muzio; Juan Briones; Mary Jane Lim-Fat; Chia-Lin Tseng; Martin Smoragiewicz; Jay Detsky; Urban Emmenegger
Journal:  J Clin Med       Date:  2022-07-18       Impact factor: 4.964

3.  Intra-Parenchymal Cerebellar Metastasis-A Rare Presentation of Castration-Resistant Prostate Cancer.

Authors:  Sufyan Ibrahim; Vyjayanth Reddy; Girish Menon
Journal:  J Neurosci Rural Pract       Date:  2022-05-25

4.  Case report: Cavernous hemangioma in the right frontoparietal junction.

Authors:  Xuemin Cao; Xiaoshuai Chen; Yi Wang; Shangang Feng; Zengwu Wang
Journal:  Front Surg       Date:  2022-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.